Nemus Bioscience Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 177M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.85
x | P/E ratio 2025 * |
-5.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.81% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
1st Jan change | Capi. | |
---|---|---|
+26.62% | 46.56B | |
+45.38% | 41.67B | |
+0.66% | 41.16B | |
+31.36% | 32.4B | |
+22.09% | 28.18B | |
-6.35% | 28.1B | |
+49.43% | 14.52B | |
+48.33% | 13.74B | |
+3.65% | 12.17B |